Current pharmacological trials to treat sarcopenia focus on the potential suitability of various agents, including appetite stimulants, protein anabolic agents, growth hormones, anabolic steroids, androgenic steroids, androgenic receptor modulators, angiotensin-converting enzyme inhibitors, troponin activators, select receptor blockers and myostatin inhibitors [15,560,561,562,563]. Here, MSTN is linked to sarcopenia.